Formoterol For Asthma: Evidence Of Serious Adverse Effects, Cochrane Researchers Review

Published: Oct 17, 2008

ScienceDaily (Oct. 17, 2008) — Asthma sufferers who regularly take the beta2-agonist formoterol are more likely to suffer non-fatal serious adverse events than those given placebos. A review carried out by Cochrane Researchers showed a significantly increased risk for people who took the drug once or twice daily for at least 12 weeks.

Back to news